Nantahala Capital Management’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-30,000
| Closed | -$254K | – | 117 |
|
|
2023
Q3 | $254K | Sell |
30,000
-64,939
| -68% | -$549K | 0.02% | 99 |
|
|
2023
Q2 | $902K | Sell |
94,939
-3,335
| -3% | -$31.7K | 0.09% | 80 |
|
|
2023
Q1 | $541K | Sell |
98,274
-5,041
| -5% | -$27.7K | 0.04% | 91 |
|
|
2022
Q4 | $839K | Sell |
103,315
-3,286
| -3% | -$26.7K | 0.05% | 77 |
|
|
2022
Q3 | $981K | Sell |
106,601
-6,499
| -6% | -$59.8K | 0.06% | 75 |
|
|
2022
Q2 | $1.29M | Sell |
113,100
-4,216
| -4% | -$48.1K | 0.06% | 74 |
|
|
2022
Q1 | $2.49M | Sell |
117,316
-9,387
| -7% | -$199K | 0.11% | 67 |
|
|
2021
Q4 | $3.67M | Buy |
126,703
+114,851
| +969% | +$3.33M | 0.13% | 66 |
|
|
2021
Q3 | $1.16M | Sell |
11,852
-648
| -5% | -$63.3K | 0.04% | 92 |
|
|
2021
Q2 | $1.63M | Hold |
12,500
| – | – | 0.05% | 86 |
|
|
2021
Q1 | $2.26M | Buy |
+12,500
| New | +$2.26M | 0.07% | 80 |
|